Remdesivir CAS:1809249-37-3CAS number : 1809249-37-3

Chemical Name : Remdesivir

Application : Agrochem or Pharmaceutical intermediates

Product Information
Structural Formula
Synonym Remdesivir
Remdesivir intermediates
Remdesivir APIs
Specifications Upon request
Packing See details
Material Safety Data Sheet Upon request
Availability Please visit www.nbinno.com for our official company website or sending email to info@nbinno.com for more information.
Product Description:

       Product Name: Remdesivir
       Synonym: Remdesivir; GS-5734; GS 5734; GS5734, Prodrug of GS-441524; Prodrug of GS441524; Prodrug of GS441524;
       CAS#: 1809249-37-3 
       Chemical Formula: C28H36N5O8P 
       Exact Mass: 601.2301 
       Molecular Weight: 601.5968 
       IUPAC/Chemical Name: 2-ethylbutyl ((S)-(((2R,3S,4R,5R)-5-(4-aminopyrrolo[1,2-b]pyridazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alaninate
       
       
               Also, we are offering steps of Remdesivir intermediates:
       
               CAS:1355357-49-1
       
               CAS:1911578-98-7
       
               CAS:1355049-92-1
       
               CAS:1191237-69-0
       
               CAS:1191237-80-5
        
       Application:
       Remdesivir has been found to show reasonable antiviral activity against more distantly related viruses such as respiratory syncytial virus, Junin virus, Lassa fever virus, and MERS-coronavirus and Coronavirus. GS-5734 was rapidly pushed through clinical trials due to the 2013–2016 West African Ebola virus epidemic crisis.
        
       Gilead Sciences has recently confirmed that it is demonstrating whether the experimental Ebola drug Remdesivir may cause a fight against a new coronavirus (2019-nCoV) emerging in China. The company said that "active discussions are underway with researchers and clinicians in the United States and China about the potential use of Remdesivir in therapy."
       Remdesivir, also known as GS-5734, is an experimental RNA polymerase inhibitor developed by Gilead Sciences in 2014 in collaboration with the Centers for Disease Control and Prevention (CDC) and the U.S. Army Medical Institute for Infectious Diseases Anthony Fossie, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (NIH), stated in a comment on JAMA Network that SARS-CoV and MERS-CoV are being used as prototypes to develop treatment strategies for 2019-nCoV. "Broad-spectrum antivirals, such as Remdesivir, lopinavir / ritonavir and interferon, have shown promise against MERS-CoV in animal models and are eva1uating their activity against 2019-nCoV," he said.

Founded in 2007, our company is a high-tech pharmaceutical and pesticide chemical company integrating R&D, production and sales.The target product of synthetic weights ranging from milligrams to kilograms. We have successfully completed a large number of orders for chemical custom synthesis on timeOur company is committed to the research and development, production and sales of bulk drugs and their intermediates, fine chemicals.Professional project management talents, perfect project management system; customized production tailored to help customers reduce capital and time costs.The company's production base is equipped with enamel reactors from 50L to 5000L, stainless steel ultra-low temperature reactors and conventional separation and drying equipment.

China supplier of Remdesivir CAS:1809249-37-3,Remdesivir factory,Remdesivir APIs manufacturer and Remdesivir producer, send us your inquiry of Remdesivir intermediates or request COA,MSDS,NMR of Remdesivir APIs.


Related Intermediates
Product Name CAS No.
4-cyanobenzylchloride CAS:874-86-2 874-86-2 View Details
2,4,5,6-Tetraaminopyrimidine sulfate CAS:5392-28-9 5392-28-9 View Details
Difurfuryl Disulfide CAS:4437-20-1 4437-20-1 View Details
isonicotinamide CAS:1453-82-3 1453-82-3 View Details
1-bromo-2-iodoethane CAS:590-16-9 590-16-9 View Details